Diseases, Conditions, Syndromes

US hoping for two COVID-19 vaccines by end of November

Two American companies expect to apply for emergency approval for their COVID-19 vaccines by late November, welcome news as the US crossed eight million confirmed cases amid a third surge of its coronavirus epidemic.

Diseases, Conditions, Syndromes

AstraZeneca, J&J vaccine trials back on track in US

Two major clinical trials for experimental COVID-19 vaccines got back on track in the United States Friday—providing a glimmer of hope as the number of cases skyrocket across the country.

Diseases, Conditions, Syndromes

S. Korea has deadliest day of pandemic amid omicron surge

South Korea saw its deadliest day of the pandemic on Saturday, reporting 112 fatalities in the latest 24-hour period, as it grapples with a wave of coronavirus infections driven by the fast-moving omicron variant.

Psychology & Psychiatry

Acute psychotic illness triggered by Brexit Referendum

Political events can take a serious toll on mental health, a doctor has warned in the journal BMJ Case Reports, after treating a man with a brief episode of acute psychosis, triggered by the 2016 Referendum on Brexit—the ...

Vaccination

Sinovac, AstraZeneca seek vaccine approval in Brazil

The manufacturers of two COVID-19 vaccines developed by Chinese pharmaceutical firm Sinovac and Oxford-AstraZeneca filed the first applications Friday for regulatory approval in hard-hit Brazil, officials said.

Diseases, Conditions, Syndromes

Systemic US reforms needed to prevent mass death in the next pandemic

Ahead of the 2024 US presidential election, The BMJ has launched a forward-looking series that highlights the lessons that can be learned from the US's COVID-19 experience and the actions that are needed to prevent the loss ...

page 1 from 8